FDA Clearance – Indication For Use:
“The BNA™ Analysis System is to be used by qualified medical professionals for the post-hoc statistical analysis of the human electroencephalogram (“EEG”), utilizing evoked response potentials (“ERP’). This device is indicated for use in individuals 14 to 24 years of age. The BNA™ Analysis System is to be used with the auditory oddball task only.”
Post-hoc statistical analysis of EEG/ERP data enables physicians to determine if the brain reacts to a task in a way that is similar to the reaction of the average normal brain. If dis-similar, how far is it from the normal reaction? This is an independent layer of objective information that can be used by physicians to gain additional clarity on brain processes.
ElMindA’s BNA™ technology is based on non-invasive recordings of multi-channel ERPs, a direct measure of neural activity, and a comprehensive and advanced analysis of these recordings to form Brain Network Activation patterns (BNAs) in order to map neural pathways that …Read More
BNA™ serves as a valuable tool in CNS drug development, providing the means to quantify drug-induced neuro-physiological changes in brain network activity. The BNA™ technology has been adopted by major pharmaceutical companies for drug development.Read More